
|Articles|January 22, 2013
ASCO 2013 Gu Intro
Cancer Network presents exclusive coverage from the American Society of Clinical Oncology (ASCO) 2013 Genitourinary Cancers Symposium. Check out the stories below for write-ups of the most important information to come out of this year's event.
Advertisement
Cancer Network presents exclusive coverage from the American Society of Clinical Oncology (ASCO) 2013 Genitourinary Cancers Symposium. Check out the stories below for write-ups of the most important information to come out of this year's event.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
2
TLD-1433 Exhibits Early Efficacy in BCG-Unresponsive NMIBC CIS
3
FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC
4
FDA Accepts NDA for Zanzalintinib/Atezolizumab in Pretreated Metastatic CRC
5



































